Archives
-
ML133 HCl: Reliable Kir2.1 Assay Design
2026-09-18
Learn how ML133 HCl, SKU B2199, can improve mechanistic interpretation in Kir2.1 channel, viability, proliferation, and migration assays. This scenario-based guide covers selectivity, dosing, solvent handling, controls, data interpretation, and practical product-selection criteria.
-
Phosbind Biotin for Reliable Phosphorylation Analysis
2026-09-18
Learn how Phos binding reagent (Phosbind) Biotin, SKU F4001, can strengthen cell viability, proliferation, and cytotoxicity studies by adding sequence-independent phosphoprotein analysis to Western Blot workflows. This scenario-based guide covers assay design, preparation, interpretation, and practical product selection.
-
Angiotensin II Workflows for Vascular Research
2026-09-17
Build controlled hypertension, vascular remodeling, and aneurysm experiments with Angiotensin II as a defined receptor-level perturbation. This practical guide connects peptide handling to endothelial, smooth muscle, and in vivo readouts while translating a landmark Sp1/Sp3 study into actionable assay design.
-
RBMS1 Loss Rewires PD-L1 Control in TNBC
2026-09-17
The reference study identifies the RNA-binding protein RBMS1 as a regulator of immune-cold triple-negative breast cancer through a post-transcriptional RBMS1–B4GALT1–PD-L1 axis. Its findings suggest that RBMS1 depletion can reduce PD-L1 stability and improve responses to checkpoint-based or cellular immunotherapy, while also defining important limits for translating this mechanism into other signaling systems.
-
Transdermal PTEN mRNA for Melanoma Immunotherapy
2026-09-16
The reference study develops hyaluronate-conjugated lipid nanoparticles containing HA-DMG for topical delivery of PTEN mRNA into melanoma. Its findings connect localized transdermal delivery with PTEN restoration, immunogenic cell death, tumor suppression, and enhanced antitumor immune activity in a preclinical model.
-
Gallein for GPCR Signaling Research
2026-09-16
Gallein is a practical G protein βγ subunit inhibitor for testing how GPCR-linked signals shape cancer invasion, immune-cell state, cardiac remodeling, and metabolic responses. This workflow-centered guide connects validated disease-model applications with the lactate–GPR81/FARP1 glucose-uptake pathway and shows how to build interpretable pharmacology experiments.
-
Metformin, EDH, and Mesenteric Vasorelaxation in Colitis
2026-09-15
This 2025 study identifies endothelium-dependent hyperpolarization as a central mechanism of metformin-induced relaxation in intestinal resistance vessels and links that response to protection of colitis-damaged mucosa. Its combination of wire myography, endothelial calcium and electrophysiology experiments, TRPV4 genetics, and a DSS colitis model provides a mechanistic framework for studying vascular contributions to intestinal inflammation.
-
Biotin-16-UTP for RNA Labeling Workflows
2026-09-15
Biotin-16-UTP enables affinity-ready RNA for detection, purification, localization, and RNA–protein studies without genetically modifying the target protein. This practical guide connects controlled in vitro transcription RNA labeling with assay design lessons from a recent endogenous-protein biosensor study.
-
Carbapenemase Transmission in Enterobacter cloacae
2026-09-14
A 2025 BMC Microbiology study mapped carbapenemase-encoding genes, mobile elements, and strain relatedness among carbapenem-resistant Enterobacter cloacae from eight teaching hospitals in Guangdong. Its findings connect plasmid-associated blaNDM-1 with multidrug resistance and efficient conjugative transfer, while ERIC-PCR indicates concurrent clonal dissemination across clinical settings.
-
CAY10499: Inhibitor of Human Hormone Sensitive Lipase
2026-09-14
CAY10499 enables controlled interrogation of HSL, MGL, and FAAH activity in biochemical, lipid-flux, and macrophage immunometabolism workflows. Its value in extracellular vesicle-driven tumor studies is complementary to ACLY inhibition: it tests downstream lipid handling without being presented as a direct ACLY inhibitor.
-
Munc18c–Syntaxin4 Control of Tumor Cell Invasion
2026-09-13
The reference study identifies Munc18c as a functional regulator of syntaxin4 during invadopodium formation, linking SNARE control to the trafficking of MT1-MMP and EGFR. Its peptide-competition and loss-of-function experiments show how disrupting the Munc18c–syntaxin4 axis reduces extracellular matrix invasion in tumor cells.
-
PARP1–FAK–COL5A1 Signaling in Ovarian Cancer
2026-09-12
The reference study establishes a cholesterol-resistant ovarian cancer model and identifies a PARP1–FAK/Src–COL5A1 axis that promotes epithelial–mesenchymal transition and tumorigenesis. Its design links chronic metabolic stress to adhesion-associated signaling, providing a mechanistic framework for cancer biology research and pathway-focused intervention studies.
-
Citrate Molarity Shapes mRNA-LNP Function
2026-09-11
The reference study shows that citrate buffer molarity can alter mRNA-LNP internalization and transfection even when conventional measurements such as average particle size, polydispersity, and encapsulation efficiency appear comparable. Its findings support treating buffer composition as a critical process variable and pairing routine quality attributes with morphology, uptake, potency, and in vivo expression analyses.
-
GW 6471: Causal PPARα Assay Design
2026-09-11
GW 6471 is a mechanistically defined PPARα antagonist for separating pathway association from causality. This article translates PFHxS zebrafish evidence into rigorous assay-design decisions for cellular metabolism research, lipid homeostasis studies, and related disease models.
-
CTP Solution (100 mM) for RNA Synthesis
2026-09-10
CTP Solution is an aqueous Cytidine-5'-triphosphate reagent for RNA synthesis, in vitro transcription, and related biochemical workflows. The K1045 formulation provides ≥99% HPLC-purity CTP at 100 mM and is designed for sensitive reactions that require controlled pH and low nuclease or phosphatase contamination.